Search

everythinglearnresearchcommunity

for

Search:↓

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Understanding where cancer cells come from helps create better prevention and treatment methods.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Androgenetic alopecia may indicate higher risk for certain diseases and mental health issues.

Lespedeza cuneata extract may help treat enlarged prostate.

24-Hydroxycholesterol reduces DHT formation in brain cancer cells, linking cholesterol and hormone metabolism.

PSA screening's effectiveness in reducing prostate cancer deaths can vary based on trial design and participant compliance.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Early hair loss may indicate prostate issues.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

New treatments for male hypogonadism are effective and should be personalized.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

Both genes and environmental factors like chemicals may contribute to the increase in hypospadias, but the exact causes are still unclear.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.